Essen, Germany – Evonik’s Comfort & Insulation business line celebrated 10 years of local production of polyurethane additives in China at the Shanghai-Xinzhuang Site.
Evonik said it has successfully delivered both consistent quality and innovative solutions to the polyurethane industry in Asia, especially in the Greater China region, building on its strong production know-how and a dedicated team.
Evonik adds that it has been supporting the PU market in the Greater China region since the mid-1990s with its first investment in local sales and technical service, and an application lab in Shanghai. Since then, Evonik said, it has continued to invest in people and resources to meet the demands of the dynamic PU market in China.
"With over 30 years experience in marketing polyurethane additives in the region, we focus on supplying products that are specially developed and produced to meet the needs of the local markets," said Dr Tammo Boinowitz, head of the Comfort & Insulation division at Evonik Industries AG, in a company statement.
The production site today is equipped to produce the highest quality silicone surfactants in support of rigid and flexible PU foaming. In addition, over the past 10 years, Evonik said, it has specifically developed and produced "more than 20 locallly made products catering for the specific needs of our customers in China and Asia."
In 2012 Evonik further invested in its technical capacities at the Shanghai lab, with the start-up of a new high-pressure rigid foaming machine.
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2011 more than 33,000 employees generated sales of around €14.5 billion and an operating profit (EBITDA) of about €2.8 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.